Literature DB >> 10549570

Ginsenoside Rh2 induces apoptosis independently of Bcl-2, Bcl-xL, or Bax in C6Bu-1 cells.

Y S Kim1, S H Jin, Y H Lee, S I Kim, J D Park.   

Abstract

In ginsenoside Rh2-treated rat glioma C6Bu-1 cells, apoptotic morphological changes, such as cell shrinkage, chromatin condensation and pyknosis were confirmed by means of electron microscopy. To evaluate whether induction of apoptosis by ginsenoside Rh2 is mediated by the members of Bcl-2 family, we first established C6Bu-1 cells overexpressing Bcl-2. It was demonstrated that the expression of Bcl-2, Bcl-xL and Bax was not altered in ginsenoside Rh2-treated C6Bu-1 cells. Bcl-2 overexpressing C6Bu-1 cells failed to prevent from ginsenoside Rh2-induced cell death. These results suggest the existence of other apoptotic pathway that requires induction of apoptosis by ginsenoside Rh2 rather than the pathway through Bcl-2, Bcl-xL or Bax in C6Bu-1 cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549570     DOI: 10.1007/bf02979151

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  8 in total

1.  Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from chinese traditional medicine.

Authors:  Bin Zhang; Zhong-Feng Wang; Mian-Zhi Tang; Yu-Liang Shi
Journal:  Invest New Drugs       Date:  2005-12       Impact factor: 3.850

2.  Oxymatrine triggers apoptosis by regulating Bcl-2 family proteins and activating caspase-3/caspase-9 pathway in human leukemia HL-60 cells.

Authors:  Jun Liu; Yazhou Yao; Huifang Ding; Renan Chen
Journal:  Tumour Biol       Date:  2014-02-23

3.  Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128.

Authors:  Nan Wu; Guo-cai Wu; Rong Hu; Mei Li; Hua Feng
Journal:  Acta Pharmacol Sin       Date:  2011-03       Impact factor: 6.150

4.  Resveratrol and black tea polyphenol combination synergistically suppress mouse skin tumors growth by inhibition of activated MAPKs and p53.

Authors:  Jasmine George; Madhulika Singh; Amit Kumar Srivastava; Kulpreet Bhui; Preeti Roy; Pranav Kumar Chaturvedi; Yogeshwer Shukla
Journal:  PLoS One       Date:  2011-08-26       Impact factor: 3.240

5.  Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh(2).

Authors:  M Tatsuka; M Maeda; T Ota
Journal:  Jpn J Cancer Res       Date:  2001-11

6.  Compound K, a metabolite of ginseng saponin, induces apoptosis via caspase-8-dependent pathway in HL-60 human leukemia cells.

Authors:  Sung-Hee Cho; Kyung-Sook Chung; Jung-Hye Choi; Dong-Hyun Kim; Kyung-Tae Lee
Journal:  BMC Cancer       Date:  2009-12-18       Impact factor: 4.430

7.  Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides.

Authors:  Patrick Ying Kit Yue; Nai Ki Mak; Yuen Kit Cheng; Kar Wah Leung; Tzi Bun Ng; David Tai Ping Fan; Hin Wing Yeung; Ricky Ngok Shun Wong
Journal:  Chin Med       Date:  2007-05-15       Impact factor: 5.455

8.  Separation of glycine-rich proteins from sea hare eggs and their anti-cancer activity against U937 leukemia cell line.

Authors:  Won Woo Lee; Won-Suck Kim; Ginnae Ahn; Kil-Nam Kim; Soo-Jin Heo; Moonjae Cho; I P Shanura Fernando; Nalae Kang; You-Jin Jeon
Journal:  EXCLI J       Date:  2016-06-01       Impact factor: 4.068

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.